Clinical Studies on Weight Loss Using HGH Fragment 176-191

 

by Staff Writer

The first drug ever to successfully stimulate the metabolism of body fat in humans is a peptide named HGH Fragment 176-191 according to a 2004 study. In comparison, another weight loss drug named Sibutramine aided in only suppressing the appetite instead of burning body fat.hgh fragment 176-191

In the study, 3 different doses were used throughout the course of 3 months. The lowest daily dose of 1 mg was the most effective. The 1 mg dose (or the equivalent of 250 mg) was taken orally and proven to be the equivalent of 250 mcg by injection. One of the conclusive results was that an average weight loss in those 3 months per subject was 6.61 pounds of body fat which is 300% more that for the test subjects who did not take the peptide.  It is interesting to note that HGH Fragment 176-191 injections did not have any effect on blood glucose levels but instead improved it along with cholesterol levels. Normal HGH does also have a negative effect on glucose levels.

No negative side effects have been noted in both clinical trials as well as feedback from the many people who where tested with HGH fragment 176-191. This is a great success because the peptide has been in use for the last 10 years in many medical circles and has been proven to work effectively. It is now considered a well-rooted and trusted peptide, which is inexpensive, non-hazardous and a very effective choice when compared to actual HGH injections and performs better that other drugs that aid in weight loss like Duramine and Adipex.

Clinical studies on HGH Fragment 176-191 highlight its effectiveness in targeting fat loss. Research shows its ability to stimulate lipolysis and inhibit fat storage without impacting blood sugar or muscle growth. These studies suggest its potential as a promising tool for body composition improvement and weight management in controlled settings.

 

follow us on Facebook